SCHEMBL18119656

SCHEMBL18119656

c1ccc2c(c1)Cc1cc3c(cc1-2)-c1ccccc1C31c2ccccc2-c2c1ccc1ncccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PGR P06401 1/20 0.32
HIF1A Q16665 2/20 0.31
MEN1 O00255 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
HTT P42858 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18161799 0.95 CYP3A4 (0.36) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL18119661 0.91 CYP1A2 (0.32) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL18119662 0.87 MAPT (0.38) CYP3A4CYP1A2CYP2C19MAPTKDM4E
SCHEMBL18161810 0.87 CYP1A2 (0.32) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL18119655 0.86 KDM4E (0.35) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL19980583 0.84 MAPT (0.47) CYP3A4CYP1A2CYP2C19MAPTKDM4E
SCHEMBL18119680 0.83 KDM4E (0.37) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL18119668 0.83 PDK2 (0.36) CYP3A4CYP1A2CYP2C19MAPTKDM4E
SCHEMBL18161802 0.82 MAPT (0.38) CYP3A4CYP1A2CYP2C19MAPTKDM4E
SCHEMBL18161798 0.81 KDM4E (0.35) CYP3A4CYP1A2CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180076392-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-15 US disclosed
US-20160293848-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076392-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME MCM7, CCNB2, CCNE2 CYP3A4 217/4885CYP1A2 85/4885CYP2C9 245/4885
US-20160293848-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP3A4 979/4885CYP1A2 945/4885CYP2C9 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.